Frequencies for first 10,000 rows of dose_vbm variable in drug2006q2 dataset : Verbatim text for dose, frequency, and | route, exactly as entered on report | Freq. Percent Cum. ----------------------------------------+----------------------------------- | 8,235 82.35 82.35 (0.25 % DILUTION 13 ML) ADMINISTERED .. | 1 0.01 82.36 (60 MG,) | 1 0.01 82.37 (800 MG) | 1 0.01 82.38 - REPORTED FORMULATION: PRE-FILLED SY.. | 1 0.01 82.39 .25MG PER DAY | 1 0.01 82.40 .4 MG, UNK | 1 0.01 82.41 .5MG AS REQUIRED | 1 0.01 82.42 .5MG PER DAY | 2 0.02 82.44 .6 MG, SIX DAYS A WEEK | 1 0.01 82.45 .6MG PER DAY | 1 0.01 82.46 0-175 MG DAILY | 1 0.01 82.47 0.005% (50 UG/ML), TWICE DAILY | 1 0.01 82.48 0.025%. APPLY LIBERAL AMOUNT TO AFFE.. | 1 0.01 82.49 0.125 MG, TID/PRN | 1 0.01 82.50 0.2 MG, UNK | 1 0.01 82.51 0.25 MG ONCE IV BOLUS | 1 0.01 82.52 0.25 MG Q DAY | 1 0.01 82.53 0.25 MG QD | 1 0.01 82.54 0.25 MG, QD | 2 0.02 82.56 0.25 MG/2 MLS BID IH | 2 0.02 82.58 0.25 MG/D | 1 0.01 82.59 0.25MG QD PO | 1 0.01 82.60 0.3 ML/DAY | 1 0.01 82.61 0.4 MG | 1 0.01 82.62 0.4MG Q DAY PO | 1 0.01 82.63 0.5 DF, BID | 1 0.01 82.64 0.5 G/D | 1 0.01 82.65 0.5 MG | 1 0.01 82.66 0.5 MG IMQ 6HR PRN AGITATION | 1 0.01 82.67 0.5 MG IMQ6 PRN | 1 0.01 82.68 0.5 MG/DAY | 1 0.01 82.69 0.5 MG/KG/DAY | 1 0.01 82.70 0.5-1AMPOULE | 1 0.01 82.71 0.6 G/D | 1 0.01 82.72 0.6 MG, UNK | 1 0.01 82.73 0.6 MG/DAY | 1 0.01 82.74 0.625 MG/2.5MG DAILY, | 1 0.01 82.75 0.625/2.5MG DAILY, | 1 0.01 82.76 0.73 MG; QD; IV | 1 0.01 82.77 0.75 MG/KG IV -14 MG- IV BOLUS | 1 0.01 82.78 1 BOTTLE 1 TIME PO | 1 0.01 82.79 1 BOTTLE OF WINE | 1 0.01 82.80 1 CAPSULE BID INH | 1 0.01 82.81 1 CAPSULE DAILY, INHALED | 1 0.01 82.82 1 CARD (0.5 CARD, 2 IN 1 D) PER ORAL | 1 0.01 82.83 1 CARD (0.5 CARD, 2 IN 1 D), PER ORAL | 1 0.01 82.84 1 DF DAILY | 1 0.01 82.85 1 DF, IV | 1 0.01 82.86 1 DF, ONCE/SINGLE | 1 0.01 82.87 1 DF, QD | 1 0.01 82.88 1 DROP BID OPHTHALMIC | 1 0.01 82.89 1 DROP BOTH EYES UP TO QID OPHTHALMIC | 1 0.01 82.90 1 G, BID | 2 0.02 82.92 1 G, QD | 2 0.02 82.94 1 G, UNK | 1 0.01 82.95 1 G/D | 1 0.01 82.96 1 G/DAY | 2 0.02 82.98 1 GM Q 12 HR IV | 1 0.01 82.99 1 IN THE MORNING AND 2 AT NIGHT | 1 0.01 83.00 1 INJECTION EVERY 3 MONTHS SQ | 1 0.01 83.01 1 MG (1 MG, 1 IN 1 D), ORAL | 1 0.01 83.02 1 MG, QD | 1 0.01 83.03 1 MG, UNK | 2 0.02 83.05 1 MG/D | 1 0.01 83.06 1 MILLIGRAM MANE | 1 0.01 83.07 1 ML/DAY | 1 0.01 83.08 1 PER NIGHT | 1 0.01 83.09 1 PILL DAY PO | 1 0.01 83.10 1 POSOLOGIC UNIT | 1 0.01 83.11 1 PUFF | 1 0.01 83.12 1 PUMP PER NOSTRIL ONCE NASAL | 1 0.01 83.13 1 RING MONTHLY VAGINAL | 1 0.01 83.14 1 SINGLE ORAL DOSE | 1 0.01 83.15 1 SPRAY ALTERNATE NOSTIL DAILY | 1 0.01 83.16 1 TAB QD | 1 0.01 83.17 1 TAB/DAY | 2 0.02 83.19 1 TABLET | 2 0.02 83.21 1 TABLET BID PO | 1 0.01 83.22 1 TABLET 2/DAY PO | 1 0.01 83.23 1 TABLET DAILY PO | 1 0.01 83.24 1 TABLET, ORAL | 1 0.01 83.25 1 TABLET, QD | 4 0.04 83.29 1% | 1 0.01 83.30 1-2 200 MG TABLETS DAILY | 1 0.01 83.31 1-2 DAY | 1 0.01 83.32 1-2 EVERY 6-8 HRS | 1 0.01 83.33 1.2 G | 1 0.01 83.34 1.23 MG DAYS 1, 4, 8, 11 Q3 WK IV | 1 0.01 83.35 1.25 MG/DAY | 1 0.01 83.36 1.2G PER DAY | 1 0.01 83.37 1.3 MG/KG/DAY | 1 0.01 83.38 1.5 G DAILY | 1 0.01 83.39 1.5 G PO BID | 1 0.01 83.40 1.5 G/D | 1 0.01 83.41 1.5 MG 1 A DAY | 1 0.01 83.42 1.5MG PER DAY | 1 0.01 83.43 1.75 MG/KG /HR-33 MG- IV DRIP | 1 0.01 83.44 1/2 6 MG BID | 1 0.01 83.45 1/2 TAB DAILY | 2 0.02 83.47 1/2 TABLET TWICE DAILY PO (DURAT.. | 1 0.01 83.48 1/2 TABLET DAILY | 2 0.02 83.50 1/4 OF A 100 MG TABLET | 1 0.01 83.51 10 MG/KG/HR | 1 0.01 83.52 10 MG/ML 4DYS | 1 0.01 83.53 10 CC | 1 0.01 83.54 10 MG | 2 0.02 83.56 10 MG TWICE IV DRIP | 2 0.02 83.58 10 MG 1 TAB ONCE /DAY PO | 1 0.01 83.59 10 MG DAILY | 2 0.02 83.61 10 MG DAILY PO | 2 0.02 83.63 10 MG ESETIMIBE 20MG -SIMVASTATIN DAI.. | 1 0.01 83.64 10 MG FREQUENCY UNSPECIFIED | 1 0.01 83.65 10 MG PO QD | 4 0.04 83.69 10 MG QD PO | 1 0.01 83.70 10 MG WEEKLY | 1 0.01 83.71 10 MG, BID | 2 0.02 83.73 10 MG, ONCE/SINGLE | 1 0.01 83.74 10 MG, QD | 4 0.04 83.78 10 MG, QHS | 1 0.01 83.79 10 MG, UNK | 5 0.05 83.84 10 MG/D | 4 0.04 83.88 10 MG/DAY | 3 0.03 83.91 10 MG/M2 | 1 0.01 83.92 10-20 MG PRN PO | 1 0.01 83.93 10/500 MG, QID | 1 0.01 83.94 10/80 | 1 0.01 83.95 100 MG | 2 0.02 83.97 100 MG IV | 1 0.01 83.98 100 MG PO BID | 1 0.01 83.99 100 MG PO Q 12 HR | 1 0.01 84.00 100 MG PO QHS | 1 0.01 84.01 100 MG Q12H IV DRIP | 1 0.01 84.02 100 MG, BID | 3 0.03 84.05 100 MG, ONCE/SINGLE | 1 0.01 84.06 100 MG, PRN | 1 0.01 84.07 100 MG, QD | 3 0.03 84.10 100 MG, TID | 1 0.01 84.11 100 MG, UNK | 3 0.03 84.14 100 MG-1000 MG/ DAY FOR 5-6 YEARS | 3 0.03 84.17 100 MG/D | 4 0.04 84.21 100 MG/DAY | 2 0.02 84.23 100 MG/M2 | 1 0.01 84.24 100-200 MG PO QHS | 1 0.01 84.25 100/50 MICROGRAM | 1 0.01 84.26 1000 MG (1 IN 1 D), INTRAVENOUS | 1 0.01 84.27 1000 MG ONCE IV DRIP [1 DOSE] | 1 0.01 84.28 1000 MG PO BID DAYS 1-14, Q3W | 1 0.01 84.29 1000 MG, BID | 2 0.02 84.31 1000 MG, BID, ORAL | 1 0.01 84.32 1000 MG, TID | 1 0.01 84.33 1000 MG/M2 (3400 MG) TWICE DAILY DAYS.. | 1 0.01 84.34 1000MG FOUR TIMES PER DAY | 1 0.01 84.35 1000MG PER DAY | 3 0.03 84.38 1000MG THREE TIMES PER DAY | 3 0.03 84.41 100MCG PER DAY | 1 0.01 84.42 100MG PER DAY | 5 0.05 84.47 100MG THREE TIMES PER DAY | 1 0.01 84.48 100MG TWICE PER DAY | 1 0.01 84.49 102 MG | 1 0.01 84.50 1020 MG | 1 0.01 84.51 1040 MG | 2 0.02 84.53 1045 MG, INTRAVENOUS | 1 0.01 84.54 1050 MG/D | 1 0.01 84.55 106 MG, ONCE/SINGLE | 1 0.01 84.56 109 MG | 4 0.04 84.60 1092 MG | 4 0.04 84.64 10MG ONCE DAILY PO | 1 0.01 84.65 10MG PER DAY | 12 0.12 84.77 10MG QD | 1 0.01 84.78 1100 MG | 1 0.01 84.79 1120 MG | 1 0.01 84.80 1145 MG | 1 0.01 84.81 1150 MG, BID | 1 0.01 84.82 12 G, TOTAL DAILY, INTRAVENOUS | 2 0.02 84.84 12 MG | 1 0.01 84.85 12 UG, BID | 1 0.01 84.86 12.5 CR DAILY | 1 0.01 84.87 12.5 MG 1 TAB AT BEDTIME PO | 1 0.01 84.88 12.5 MG PO DAILY | 1 0.01 84.89 12.5 MG PO Q HS | 1 0.01 84.90 12.5 MG PO TID | 1 0.01 84.91 12.5 MG, ONCE/SINGLE | 1 0.01 84.92 12.5 MG, ORAL | 1 0.01 84.93 12.5-150 MG DAILY | 1 0.01 84.94 12.5MG ONCE IV DRIP | 1 0.01 84.95 12.5MG PER DAY | 1 0.01 84.96 120 MG, QD | 1 0.01 84.97 120 MG, TID | 2 0.02 84.99 120 MG/D | 1 0.01 85.00 120 MG/DAY | 2 0.02 85.02 1200MG PER DAY | 1 0.01 85.03 120MCG WEEKLY SQ | 1 0.01 85.04 120MG PER DAY | 1 0.01 85.05 125 MG | 1 0.01 85.06 125 MG 2/D PO | 2 0.02 85.08 125 MG, BID | 1 0.01 85.09 125 MG, QHS | 1 0.01 85.10 125 MG/D | 2 0.02 85.12 1250 MG / TWICE PER DAY / | 1 0.01 85.13 1250 MG, QD | 2 0.02 85.15 1250MG PER DAY | 1 0.01 85.16 12540 ONCE DAILY IV BOLUS | 1 0.01 85.17 12MG PER DAY | 1 0.01 85.18 13.5 GM CONTIN. INFUSION | 1 0.01 85.19 1300 MG | 1 0.01 85.20 1330 MG | 1 0.01 85.21 14 IU, QD | 1 0.01 85.22 14.7 GM, TWO PUFFS TWICE DAILY AS NEE.. | 1 0.01 85.23 145 MG, QD | 2 0.02 85.25 14MG PER DAY | 1 0.01 85.26 15 MG | 1 0.01 85.27 15 MG, UNK | 1 0.01 85.28 15 MG/D | 1 0.01 85.29 15 MG/DAY | 1 0.01 85.30 15 MG/M2 | 1 0.01 85.31 15 MG/M2 QD X 21 DAYS PO | 1 0.01 85.32 15 UNITS Q AM | 1 0.01 85.33 15-7.5MG | 1 0.01 85.34 150 MG / TWICE PER DAY / | 1 0.01 85.35 150 MG DAILY | 1 0.01 85.36 150 MG PO BID | 1 0.01 85.37 150 MG PO QD | 1 0.01 85.38 150 MG, BID | 5 0.05 85.43 150 MG, QHS | 1 0.01 85.44 150 MG, SUBCUTANEOUS | 1 0.01 85.45 150 MG/D | 4 0.04 85.49 150 MG; | 1 0.01 85.50 150 UG/HR (ONE 100 UG/HR PATCH AND ON.. | 1 0.01 85.51 1500 MG 2/D PO | 1 0.01 85.52 1500 MG 3/D PO | 1 0.01 85.53 1500 MG, QD | 3 0.03 85.56 1500 MG, TOTAL DAILY, ORAL | 2 0.02 85.58 150MG 1X A DAY PO | 1 0.01 85.59 150MG PER DAY | 2 0.02 85.61 150MG SEE DOSAGE TEXT | 1 0.01 85.62 150MG TWICE PER DAY | 3 0.03 85.65 15MG 1BID PO | 1 0.01 85.66 15MG PER DAY | 1 0.01 85.67 160 MG, QD | 2 0.02 85.69 160 MG, QOD | 1 0.01 85.70 160 MG/DAY | 1 0.01 85.71 160 ML/DAY | 1 0.01 85.72 160/25 MG TABLET, 1 TABLET PER DAY. | 1 0.01 85.73 1600 MG, UNK | 1 0.01 85.74 168 MG ONCE IV | 1 0.01 85.75 16MG PER DAY | 1 0.01 85.76 17.5 MG WEEKLY SC | 1 0.01 85.77 175 MG | 2 0.02 85.79 175 MG, BID | 1 0.01 85.80 1750 MG, QD | 2 0.02 85.82 1764MG QOW X 1 WEEK | 1 0.01 85.83 180 MG 1 A DAY | 1 0.01 85.84 180 MG/M2 | 1 0.01 85.85 1800 MG, QD | 1 0.01 85.86 190 MG/525 MG EVERY 3 WEEKS | 1 0.01 85.87 1980MG PER DAY | 1 0.01 85.88 1G PER DAY | 4 0.04 85.92 1G Q12H IV | 1 0.01 85.93 1G THREE TIMES PER DAY | 2 0.02 85.95 1G TID, IV | 1 0.01 85.96 1G TWICE PER DAY | 1 0.01 85.97 1MG AS REQUIRED | 1 0.01 85.98 1MG PER DAY | 5 0.05 86.03 1MG TWICE PER DAY | 1 0.01 86.04 1ML SINGLE DOSE | 1 0.01 86.05 1ML TWICE PER DAY | 2 0.02 86.07 1PUFF PER DAY | 1 0.01 86.08 1PUFF TWICE PER DAY | 8 0.08 86.16 1SPR TWICE PER DAY | 1 0.01 86.17 1ST DOSE, 5MG/KG | 1 0.01 86.18 1TAB PER DAY | 5 0.05 86.23 1TAB TWICE PER DAY | 2 0.02 86.25 1U PER DAY | 1 0.01 86.26 1UNIT PER DAY | 3 0.03 86.29 1UNIT THREE TIMES PER DAY | 2 0.02 86.31 2 G, TID, INTRAVENOUS | 1 0.01 86.32 2 CAP QHS | 1 0.01 86.33 2 DF CON IV | 1 0.01 86.34 2 G / DAY | 1 0.01 86.35 2 G/D | 1 0.01 86.36 2 GY | 3 0.03 86.39 2 LITERS/MINUTE | 2 0.02 86.41 2 MCG/KG/MINUTE FOR 18 HOURS CONSTATN.. | 1 0.01 86.42 2 MG | 3 0.03 86.45 2 MG DAY 1, 4, 7,11 IV BOLUS | 1 0.01 86.46 2 MG DAILY | 1 0.01 86.47 2 MG GOING TO 5 MG Q HS | 1 0.01 86.48 2 MG, Q2H | 1 0.01 86.49 2 MG, QD | 1 0.01 86.50 2 MG, QD (MANE) | 1 0.01 86.51 2 MG, TID | 1 0.01 86.52 2 MG/240 MG | 1 0.01 86.53 2 MG/D | 1 0.01 86.54 2 MG; | 1 0.01 86.55 2 MG;HS;ORAL ; 3 MG;HS;ORAL | 1 0.01 86.56 2 OR 3 INFUSIONS ON UNKNOWN DATES | 1 0.01 86.57 2 TAB-50 MG- DAILY PO | 1 0.01 86.58 2 TABLETS | 1 0.01 86.59 2 TABLETS (DAILY INTERVAL: EVERY DAY).. | 1 0.01 86.60 2 TO 3 TIMES A DAY | 1 0.01 86.61 2 UG PER DAY | 1 0.01 86.62 2 X DAILY (DOSE UNSPECIFIED) | 1 0.01 86.63 2.25 MG, ONCE/SINGLE | 1 0.01 86.64 2.5 MG | 1 0.01 86.65 2.5 MG DAILY | 1 0.01 86.66 2.5 MG EACH EVENING ORAL | 1 0.01 86.67 2.5 MG IN THE EVENING | 1 0.01 86.68 2.5 MG ONE DOSE IV | 1 0.01 86.69 2.5 MG, BID | 1 0.01 86.70 2.5 MG, QD | 4 0.04 86.74 2.5 MG, QD (MORNING) | 1 0.01 86.75 2.5 MG, UNK | 3 0.03 86.78 2.5 MG/25 MG 1 DF | 1 0.01 86.79 2.5 MG/D | 1 0.01 86.80 2.5G PER DAY | 1 0.01 86.81 2.5MG PER DAY | 2 0.02 86.83 2.5MG QID PRN INHALATION | 1 0.01 86.84 2.5ML PER DAY | 1 0.01 86.85 2.5ML TWICE PER DAY | 1 0.01 86.86 20 MG 1 PER DAY PO | 1 0.01 86.87 20 MG DAILY PO | 1 0.01 86.88 20 MG DEPO-MEDROL 2 INJECTION FACET B.. | 1 0.01 86.89 20 MG FREQUENCY UNSPECIFIED | 1 0.01 86.90 20 MG PO QD | 1 0.01 86.91 20 MG PO QHS | 1 0.01 86.92 20 MG Q DAY | 1 0.01 86.93 20 MG QD PO | 1 0.01 86.94 20 MG, BID | 1 0.01 86.95 20 MG, ONCE/SINGLE | 1 0.01 86.96 20 MG, QD | 4 0.04 87.00 20 MG, QD (NOCTE) | 1 0.01 87.01 20 MG, QOD | 1 0.01 87.02 20 MG, SINGLE | 1 0.01 87.03 20 MG, UNK | 3 0.03 87.06 20 MG/D | 4 0.04 87.10 20 MG/DAY | 5 0.05 87.15 20 MG/KG, UNK | 1 0.01 87.16 20 U EACH MORNING, SUBCUTANEOUS | 1 0.01 87.17 20 U, DAILY (1/D), SUBCUTANEOUS; AS N.. | 1 0.01 87.18 20 UNK; QD | 1 0.01 87.19 200 IU, QD | 1 0.01 87.20 200 MCG, QD | 1 0.01 87.21 200 MG MORNING PO; 300 MG BEDTI.. | 1 0.01 87.22 200 MG (1 IN 1 D), INTRAVENOUS | 1 0.01 87.23 200 MG 3 DOSES | 1 0.01 87.24 200 MG BID PO | 1 0.01 87.25 200 MG DAILY | 1 0.01 87.26 200 MG IV | 1 0.01 87.27 200 MG PO QHS | 1 0.01 87.28 200 MG QM SUBCUTANEOUS | 1 0.01 87.29 200 MG TWICE PER DAY | 1 0.01 87.30 200 MG, BID | 4 0.04 87.34 200 MG, ONCE/SINGLE | 1 0.01 87.35 200 MG, ORAL | 1 0.01 87.36 200 MG, QD | 3 0.03 87.39 200 MG, QID, ORAL | 1 0.01 87.40 200 MG, UNK | 3 0.03 87.43 200 MG/D | 4 0.04 87.47 200 MG/DAY | 5 0.05 87.52 200 MICROGRAMS | 1 0.01 87.53 200 UG DAILY IV | 1 0.01 87.54 200 UG/D | 1 0.01 87.55 2000 MG, ONCE/SINGLE | 1 0.01 87.56 200MCG QIDPRN ORAL AER I | 1 0.01 87.57 200MCG TWICE PER DAY | 1 0.01 87.58 200MG Q2WKS SC | 1 0.01 87.59 200MG QAM, 500MG QHS | 1 0.01 87.60 200MG/BODY=153.8MG/M2 | 1 0.01 87.61 200MGM2 PER DAY | 2 0.02 87.63 20MG 1 | 1 0.01 87.64 20MG DAILY PO (DURATION: SEVERA.. | 1 0.01 87.65 20MG 7:45 MORNING | 1 0.01 87.66 20MG DAILY | 1 0.01 87.67 20MG IV X 1 | 1 0.01 87.68 20MG PER DAY | 9 0.09 87.77 20MG QAM, 10MG QPM PO | 1 0.01 87.78 20MG TWICE PER DAY | 2 0.02 87.80 20MG UNKNOWN | 1 0.01 87.81 2150 MG TWICE A DAY FOR 2 WEEKS, Q3W | 1 0.01 87.82 21MG PER DAY | 2 0.02 87.84 22.5 MG WEEKLY SC | 1 0.01 87.85 22.9 MG | 1 0.01 87.86 225 MG BID PO | 1 0.01 87.87 225 MG QD | 1 0.01 87.88 225 MG, UNK | 1 0.01 87.89 225 MG/D | 1 0.01 87.90 225 UG/DAY | 1 0.01 87.91 2300 MG | 1 0.01 87.92 24 IU, QD | 1 0.01 87.93 240 MG PO QD | 1 0.01 87.94 240MG QD PO | 1 0.01 87.95 240MG THREE TIMES PER DAY | 1 0.01 87.96 24MG PER DAY | 1 0.01 87.97 25 - 425 MG, UNK | 1 0.01 87.98 25 MCG. 2 SPRAYS IN EACH NOSTRIL DAILY. | 1 0.01 87.99 25 MCG/H 72 HOURS TRANSDERMAL | 1 0.01 88.00 25 MG | 1 0.01 88.01 25 MG DAILY PO | 1 0.01 88.02 25 MG 1 OR 2/DAY | 1 0.01 88.03 25 MG DAILY | 1 0.01 88.04 25 MG PO BID | 1 0.01 88.05 25 MG PO QD | 2 0.02 88.07 25 MG TWICE DAILY PO | 1 0.01 88.08 25 MG, BID | 1 0.01 88.09 25 MG, PRN | 1 0.01 88.10 25 MG, QD | 3 0.03 88.13 25 MG, UNK | 1 0.01 88.14 25 MG/D | 2 0.02 88.16 25 MG/DAY | 3 0.03 88.19 25 UG, Q72H | 1 0.01 88.20 25/100 | 1 0.01 88.21 250 MG / DAY | 1 0.01 88.22 250 MG BID X 10 D | 1 0.01 88.23 250 MG PO BID | 1 0.01 88.24 250 MG, BID | 3 0.03 88.27 250 MG, ONCE/SINGLE | 1 0.01 88.28 250 MG, QD | 4 0.04 88.32 250 MG/D | 1 0.01 88.33 250 MG/DAY | 1 0.01 88.34 250 ML/HR OVER 60 MINUTES EVERY 12 HRS | 1 0.01 88.35 2500MG PER DAY | 1 0.01 88.36 250MG PER DAY | 4 0.04 88.40 250MG THREE TIMES PER DAY | 1 0.01 88.41 25MG BID PO | 1 0.01 88.42 25MG UNKNOWN | 1 0.01 88.43 260 MG, UNK | 1 0.01 88.44 27.5 MG / DAY | 2 0.02 88.46 2700 MG; IV | 1 0.01 88.47 274 MG | 1 0.01 88.48 2G PER DAY | 3 0.03 88.51 2MG QD PO (DURATION: SEVERAL .. | 1 0.01 88.52 2MG PER DAY | 4 0.04 88.56 2PUFF TWICE PER DAY | 1 0.01 88.57 2Q6HR PRN (NOT EXCEED 8 TAB DAILY) | 1 0.01 88.58 2TAB PER DAY | 2 0.02 88.60 3 G, QD | 1 0.01 88.61 3 G, QD, ORAL | 1 0.01 88.62 3 MG | 1 0.01 88.63 3 MG QD | 1 0.01 88.64 3 MG, BID | 1 0.01 88.65 3 MG, UNK | 1 0.01 88.66 3 MG/DAY | 1 0.01 88.67 3 MG/KG/D | 1 0.01 88.68 3 MG/KG/DAY | 1 0.01 88.69 3 MIU, TIW | 1 0.01 88.70 3 PATCHES OF 75UG/HR. | 1 0.01 88.71 3 PER DAY | 1 0.01 88.72 3 VIALS | 4 0.04 88.76 3 X DOSE UNSPECIFIED | 2 0.02 88.78 3,000 MG, UNK | 1 0.01 88.79 3.375 GM EVERY 6 HOURS IV BOLUS | 1 0.01 88.80 3.375GM ONE TIME IV DRIP | 1 0.01 88.81 3.5 MG, ONCE/SINGLE | 1 0.01 88.82 30 MG | 1 0.01 88.83 30 MG 2 TIMES A DAY | 1 0.01 88.84 30 MG DAILY | 1 0.01 88.85 30 MG PER WEEK | 1 0.01 88.86 30 MG PO BID | 1 0.01 88.87 30 MG, Q3MO | 1 0.01 88.88 30 MG, QD | 2 0.02 88.90 30 MG, QD, ORAL | 1 0.01 88.91 30 MG, UNK | 1 0.01 88.92 30 MG/D | 1 0.01 88.93 30 MG/D OR 2 DOSES A DAY UNK | 1 0.01 88.94 30 MG/DAY | 2 0.02 88.96 30 UG; QW; IM | 1 0.01 88.97 30 UG;QW;IM | 1 0.01 88.98 30-45 MG DOSE, TWO TO THREE 15 MG TA.. | 1 0.01 88.99 30/500MG PRN | 1 0.01 89.00 300 MCG | 1 0.01 89.01 300 MG | 1 0.01 89.02 300 MG (100 MG, 3 IN 1 D), ORAL | 1 0.01 89.03 300 MG / TWICE PER DAY / | 1 0.01 89.04 300 MG AM - 750 MG PM/DAY | 1 0.01 89.05 300 MG DAILY | 1 0.01 89.06 300 MG ONCE - ORAL | 1 0.01 89.07 300 MG PO BID | 1 0.01 89.08 300 MG QD ORAL | 2 0.02 89.10 300 MG TID PO | 1 0.01 89.11 300 MG, BID | 2 0.02 89.13 300 MG, BID, INHALATION | 2 0.02 89.15 300 MG, Q2W, SUBCUTANEOUS | 2 0.02 89.17 300 MG, QD | 3 0.03 89.20 300 MG, QMO | 1 0.01 89.21 300 MG, UNK | 4 0.04 89.25 300 MG/D | 2 0.02 89.27 300 MG/DAY | 3 0.03 89.30 300 MG/DAY FOR TWO MONTHS PRIOR TO ST.. | 1 0.01 89.31 300, QW2, SUBCUTANEOUS | 1 0.01 89.32 3000 MG | 1 0.01 89.33 300MG PER DAY | 4 0.04 89.37 300MG TWICE PER DAY | 2 0.02 89.39 305 MG, UNK | 1 0.01 89.40 30MG PER DAY | 5 0.05 89.45 30MG UNKNOWN | 1 0.01 89.46 3150 MG | 1 0.01 89.47 32 X 8MG TABLETS, 17 X 2MG - TOTAL 29.. | 1 0.01 89.48 325 MG, QD | 1 0.01 89.49 336 MG | 1 0.01 89.50 35 U, QD | 1 0.01 89.51 350 MG Q21 D IV BOLUS | 1 0.01 89.52 350 MG, UNK | 1 0.01 89.53 350 MG/DAY | 1 0.01 89.54 3510 MG | 1 0.01 89.55 35MG WEEKLY PO | 1 0.01 89.56 3600 MG, ONCE/SINGLE | 1 0.01 89.57 37 U EACH MORNING, SUBCUTANEOUS | 1 0.01 89.58 37.5 MG, QD | 1 0.01 89.59 37.5 MG, UNK | 1 0.01 89.60 37.5 MG/DAY | 2 0.02 89.62 37.5/25 DAILY | 1 0.01 89.63 375 MG, BID, ORAL | 1 0.01 89.64 375 MG, SUBCUTANEOUS | 1 0.01 89.65 380 MG ONCE IV BOLUS | 1 0.01 89.66 3CAP TWICE PER DAY | 1 0.01 89.67 3CC 0.5 % MARCAINE 2 INJECTION FACET .. | 1 0.01 89.68 3G PER DAY | 1 0.01 89.69 3TAB PER DAY | 2 0.02 89.71 3U PER DAY | 1 0.01 89.72 4 DF, PO | 1 0.01 89.73 4 DRPS/DAY | 1 0.01 89.74 4 G DAILY | 1 0.01 89.75 4 G/D | 1 0.01 89.76 4 MG | 2 0.02 89.78 4 MG DAILY PO | 1 0.01 89.79 4 MG EVERY 28 DAYS | 1 0.01 89.80 4 MG EVERY 3 TO 4 WEEKS | 1 0.01 89.81 4 MG EVERY 4 WEEKS | 1 0.01 89.82 4 MG EVERY 6 WEEKS | 1 0.01 89.83 4 MG EVERY MONTH | 1 0.01 89.84 4 MG IN THE MORNING | 1 0.01 89.85 4 MG MONTHLY | 1 0.01 89.86 4 MG PO QD | 1 0.01 89.87 4 MG PO QHS | 1 0.01 89.88 4 MG, ANNUAL | 1 0.01 89.89 4 MG, BID | 1 0.01 89.90 4 MG, ONCE/SINGLE | 1 0.01 89.91 4 MG, QD | 3 0.03 89.94 4 MG, QMO | 15 0.15 90.09 4 MG, TIW | 1 0.01 90.10 4 MG, UNK | 1 0.01 90.11 4 MGMD QD PO | 1 0.01 90.12 4 MILLIGRAMS MANE | 1 0.01 90.13 4 PUFFS DAILY | 1 0.01 90.14 4 TABS X 1 VAGINAL DOSE | 1 0.01 90.15 4 X UNSPECIFIED DOSE | 1 0.01 90.16 4.5 G, Q8H | 1 0.01 90.17 4.5 GM Q8 H | 1 0.01 90.18 4.5 MG, UNK | 1 0.01 90.19 4.8 MG | 1 0.01 90.20 4.8 MG, QD | 1 0.01 90.21 40 MG DAILY | 2 0.02 90.23 40 MG EVERY OTHER WEEK SQ | 1 0.01 90.24 40 MG PO DAILY | 2 0.02 90.26 40 MG PO QD | 2 0.02 90.28 40 MG Q DAY PO | 1 0.01 90.29 40 MG QD | 1 0.01 90.30 40 MG QD PO | 1 0.01 90.31 40 MG, BID | 5 0.05 90.36 40 MG, ONCE/SINGLE | 1 0.01 90.37 40 MG, Q12H | 2 0.02 90.39 40 MG, QD | 6 0.06 90.45 40 MG, UNK | 4 0.04 90.49 40 MG/D | 2 0.02 90.51 40 MG/DAY | 4 0.04 90.55 40 UG BID INHALATION | 1 0.01 90.56 40 UG/KG, UNK | 2 0.02 90.58 400 MG /DAY | 1 0.01 90.59 400 MG DAILY | 4 0.04 90.63 400 MG MG/M2 FOLLOWED BY 240 MG/M2 OV.. | 1 0.01 90.64 400 MG PO QD | 1 0.01 90.65 400 MG PO X 1 THEN 200 MG QD X 4 DAYS | 1 0.01 90.66 400 MG Q 21 IV BOLUS | 1 0.01 90.67 400 MG Q24H IV BOLUS | 1 0.01 90.68 400 MG QDAY | 1 0.01 90.69 400 MG, IV | 1 0.01 90.70 400 MG, QD | 7 0.07 90.77 400 MG, UNK | 1 0.01 90.78 400 MG/D | 3 0.03 90.81 400 MG/DAY | 3 0.03 90.84 400 MG/M2 FOLLOWED BY A WEEKLY INFUSI.. | 1 0.01 90.85 400 MG;Q48H;IV | 1 0.01 90.86 400 UG, BID | 1 0.01 90.87 400 UG, UNK | 1 0.01 90.88 400MG 8 PM, 400MG AM BID PO | 1 0.01 90.89 400MG BEDTIME PO | 1 0.01 90.90 400MG TID PO | 1 0.01 90.91 400MG PER DAY | 4 0.04 90.95 400MG TO 600MG DAILY | 1 0.01 90.96 400MG TWICE PER DAY | 2 0.02 90.98 400MG/BODY=307.7MG/M2IN BOLUS THEN 25.. | 1 0.01 90.99 4050 MCG | 1 0.01 91.00 40MG PER DAY | 2 0.02 91.02 40MG TWICE PER DAY | 1 0.01 91.03 41 U, QD | 2 0.02 91.05 420 MG | 1 0.01 91.06 4200 MG | 1 0.01 91.07 430 MG, UID/QD, IV NOS | 1 0.01 91.08 44 MCG, 3 IN 1 WEEKS, SUBCUTANEOUS; 2.. | 1 0.01 91.09 440MG PER DAY | 1 0.01 91.10 45 MG, QHS | 1 0.01 91.11 450 MG | 1 0.01 91.12 450 UG/D | 1 0.01 91.13 4500MG PER DAY | 1 0.01 91.14 4550 MG | 1 0.01 91.15 4580 MG | 1 0.01 91.16 45MG PER DAY | 1 0.01 91.17 4G EVERY 3-4 WEEKS | 1 0.01 91.18 4G PER DAY | 1 0.01 91.19 4MG CYCLIC | 1 0.01 91.20 4MG PER DAY | 8 0.08 91.28 4MG Q12H 1HR PRECHEM + 12H POST | 1 0.01 91.29 4MG QMO | 1 0.01 91.30 4MG THREE TIMES PER DAY | 2 0.02 91.32 4MG TWICE PER DAY | 1 0.01 91.33 4MG UNKNOWN | 1 0.01 91.34 4MG/4WEEKS | 1 0.01 91.35 4ML SINGLE DOSE | 1 0.01 91.36 4TAB PER DAY | 1 0.01 91.37 4TABS PER DAY | 1 0.01 91.38 4TH DOSE. STOPPED AFTER 6 MINUTES. | 1 0.01 91.39 5 CYCLES WITH CARBOPLATIN | 1 0.01 91.40 5 CYCLES WITH TAXOTERE | 1 0.01 91.41 5 MG | 3 0.03 91.44 5 MG DAILY IN EVENING PO | 1 0.01 91.45 5 MG BID PO | 1 0.01 91.46 5 MG 2 TABS ONCE/DAYPO | 1 0.01 91.47 5 MG BID | 1 0.01 91.48 5 MG DAILY | 1 0.01 91.49 5 MG EVERY 4-6 HOURS PRN | 1 0.01 91.50 5 MG IN THE MORNING AND 1.25 MG IN TH.. | 2 0.02 91.52 5 MG IV X 1 | 1 0.01 91.53 5 MG PER DAY | 1 0.01 91.54 5 MG PO QD | 1 0.01 91.55 5 MG Q DAY | 1 0.01 91.56 5 MG Q DAY PO | 1 0.01 91.57 5 MG QD 3 DAYS/WK - 7.5 MG QD 4 DAYS/WK | 1 0.01 91.58 5 MG QD ORAL | 1 0.01 91.59 5 MG, BID | 2 0.02 91.61 5 MG, Q12H | 1 0.01 91.62 5 MG, QD | 8 0.08 91.70 5 MG, QD (EVERY MORNING) | 1 0.01 91.71 5 MG, QD/WEAN | 1 0.01 91.72 5 MG, QHS | 1 0.01 91.73 5 MG, QID | 1 0.01 91.74 5 MG, TID | 2 0.02 91.76 5 MG, UNK | 2 0.02 91.78 5 MG/2 DAYS | 1 0.01 91.79 5 MG/D | 1 0.01 91.80 5 MG/DAILY | 1 0.01 91.81 5 MG/DAY | 2 0.02 91.83 5 MG/KG | 5 0.05 91.88 5 MG/KG/DAY | 1 0.01 91.89 5 ML ONCE INTRADERM | 1 0.01 91.90 5 UNITS AC | 1 0.01 91.91 5,000 UNIT/ML | 1 0.01 91.92 5-10 MG NIGHTLY | 1 0.01 91.93 5-625 MG, QD | 1 0.01 91.94 5.6ML PER DAY | 1 0.01 91.95 5/500 1-2QH4PRN PO | 1 0.01 91.96 50 MG TWICE A DAY PO | 1 0.01 91.97 50 MG (50 MG, 1 IN 1 D), ORAL | 1 0.01 91.98 50 MG / DAY | 2 0.02 92.00 50 MG FREQUENCY UNSPECIFIED | 1 0.01 92.01 50 MG PO | 1 0.01 92.02 50 MG PO Q6H | 1 0.01 92.03 50 MG PO QHS | 1 0.01 92.04 50 MG PO QTD PRN | 1 0.01 92.05 50 MG Q DAY | 1 0.01 92.06 50 MG TID | 1 0.01 92.07 50 MG TID PO | 1 0.01 92.08 50 MG, BID | 1 0.01 92.09 50 MG, FREQUENCY UNSPECIFIED | 1 0.01 92.10 50 MG, INTRAVENOUS | 1 0.01 92.11 50 MG, Q 2WEEKS | 1 0.01 92.12 50 MG, Q12H | 1 0.01 92.13 50 MG, QD | 2 0.02 92.15 50 MG, TID | 1 0.01 92.16 50 MG, UNK | 3 0.03 92.19 50 MG/D | 2 0.02 92.21 50 MG/DAY | 3 0.03 92.24 50 MG/ML, TWICE MONTHLY | 1 0.01 92.25 50 ONCE DAILY IV BOLUS | 1 0.01 92.26 50-100 MG | 1 0.01 92.27 500 + 125 MG DAILY | 1 0.01 92.28 500 MCG QID ORAL AER INH | 1 0.01 92.29 500 MG 3 TIMES DAILY PO | 1 0.01 92.30 500 MG (1 IN 1 D), ORAL | 1 0.01 92.31 500 MG /D PO | 1 0.01 92.32 500 MG 3 X DAY | 1 0.01 92.33 500 MG AM - 750 MG PM/DAY | 1 0.01 92.34 500 MG AM AND PM PO | 1 0.01 92.35 500 MG BID | 1 0.01 92.36 500 MG PO BID | 1 0.01 92.37 500 MG PO BID , 1000 MG QHS | 1 0.01 92.38 500 MG, BID | 5 0.05 92.43 500 MG, BID, ORAL | 2 0.02 92.45 500 MG, INTRAVENOUS | 1 0.01 92.46 500 MG, QD | 1 0.01 92.47 500 MG, QID | 1 0.01 92.48 500 MG, TID | 2 0.02 92.50 500 MG, UNK | 2 0.02 92.52 500 MG-1000 MG BID IF NEEDED | 1 0.01 92.53 500 MG. 2 TIMES DAILY PO | 1 0.01 92.54 500 MG/2 DAYS | 1 0.01 92.55 500 MG/400 IU BID | 1 0.01 92.56 500 MG/D | 1 0.01 92.57 500 MG/DAY | 1 0.01 92.58 500 MG/KG / 100 MG | 1 0.01 92.59 500MCG PER DAY | 1 0.01 92.60 500MCG/2.5ML | 1 0.01 92.61 500MG PER DAY | 2 0.02 92.63 500MG TWICE PER DAY | 3 0.03 92.66 50MCG TWICE PER DAY | 1 0.01 92.67 50MG PER DAY | 2 0.02 92.69 50MG Q12H | 1 0.01 92.70 510 MG | 1 0.01 92.71 53 MG, ONCE/SINGLE | 1 0.01 92.72 53.1 MG WEEKLY IV | 1 0.01 92.73 55/100, TWICE PER DAY INHALED | 1 0.01 92.74 570 MG | 1 0.01 92.75 580MG PER DAY | 1 0.01 92.76 5MG DAILY PO | 1 0.01 92.77 5MG PER DAY | 3 0.03 92.80 5MG PO 1 HOUR PRIOR TO INTERCOURSE | 1 0.01 92.81 5MG, Q HS, BY MOUTH | 1 0.01 92.82 5ML 2 | 1 0.01 92.83 5ML FOUR TIMES PER DAY | 1 0.01 92.84 6 CYCLES | 1 0.01 92.85 6 CYCLES WEEKLY WITH EMCYT | 1 0.01 92.86 6 MG | 1 0.01 92.87 6 MG IV X 1 , 12MG IV X 2 | 1 0.01 92.88 6 MG, BID | 6 0.06 92.94 6 MG, QD | 1 0.01 92.95 6 MG, UNK | 1 0.01 92.96 6 MG/KG/DAY | 1 0.01 92.97 6 UNK, UNK | 1 0.01 92.98 6.5% SOLUTION. PLACE 2 DROPES IN EAC.. | 1 0.01 92.99 60 MG | 2 0.02 93.01 60 MG BID PO | 1 0.01 93.02 60 MG ONCE PO | 1 0.01 93.03 60 MG QD PO | 1 0.01 93.04 60 MG QHS PO | 2 0.02 93.06 60 MG, BID | 1 0.01 93.07 60 MG, QD | 1 0.01 93.08 60 MG, UNK | 1 0.01 93.09 60 UNITS A.M., 40 UNITS P.M., SUBCUTA.. | 1 0.01 93.10 600 MG | 2 0.02 93.12 600 MG BID PO | 1 0.01 93.13 600 MG MANE, 1500 MG NOCTE | 1 0.01 93.14 600 MG TWICE DAY PO | 1 0.01 93.15 600 MG, BID | 1 0.01 93.16 600 MG, QD | 1 0.01 93.17 600 MG, TID | 3 0.03 93.20 600 MG/DAY | 3 0.03 93.23 600-700 MG DAILY | 1 0.01 93.24 600MG A DAY | 1 0.01 93.25 600MG MANE + 1575MG NOCTE | 1 0.01 93.26 600MG PER DAY | 5 0.05 93.31 60MG PER DAY | 1 0.01 93.32 60MGM2 PER DAY | 1 0.01 93.33 62.5 MG/D | 1 0.01 93.34 625MG PER DAY | 1 0.01 93.35 6300 MG | 1 0.01 93.36 635 MCI, 6 DOSES, PO | 1 0.01 93.37 650 MG IV BOLUS THEN 970 IV CONTINUOU.. | 2 0.02 93.39 69000 UNIT | 1 0.01 93.40 6U/H EPIDURAL | 1 0.01 93.41 7 MG PO QD | 1 0.01 93.42 7 MG/D | 1 0.01 93.43 7 U, DAILY (1/D), SUBCUTANEOUS | 1 0.01 93.44 7.5 MG FREQUENCY UNSPECIFIED | 1 0.01 93.45 7.5 MG IN THE MORNING | 1 0.01 93.46 7.5 MG PO QD | 1 0.01 93.47 7.5 MG QD EXCEPT 11.25 MON, WED, FRI | 1 0.01 93.48 7.5 MG/D OR 3 DOSES A DAY UNK | 1 0.01 93.49 7.5/500 MG 1-2 EVERY 4-6 HRS AS NEEDED | 1 0.01 93.50 7.5MG HYDROCODONE/500MG PARACETAMOL/PRN | 1 0.01 93.51 7.5MG PER DAY | 1 0.01 93.52 7.5ML TWICE PER DAY | 1 0.01 93.53 70 MG/D | 1 0.01 93.54 700 MG/D | 1 0.01 93.55 7000 MG | 1 0.01 93.56 700MG PER DAY | 1 0.01 93.57 70MGM2 PER DAY | 2 0.02 93.59 720 MG | 1 0.01 93.60 75 MG DAILY PO | 1 0.01 93.61 75 MG BID PO | 1 0.01 93.62 75 MG DAILY | 1 0.01 93.63 75 MG QD | 1 0.01 93.64 75 MG QD - ORAL | 2 0.02 93.66 75 MG, BID | 1 0.01 93.67 75 MG, FREQUENCY UNKNOWN | 1 0.01 93.68 75 MG, TIW | 1 0.01 93.69 75 MG, UNK | 1 0.01 93.70 75 MG/D | 4 0.04 93.74 750 MG | 1 0.01 93.75 750 MG TID | 1 0.01 93.76 750 MG TWICE A DAY PO | 1 0.01 93.77 750 MG, BID, ORAL | 1 0.01 93.78 750 MG/D | 1 0.01 93.79 75MG PER DAY | 2 0.02 93.81 75MG THREE TIMES PER DAY | 1 0.01 93.82 79.2 MG | 1 0.01 93.83 8 MG | 1 0.01 93.84 8 MG GIVEN ON 22 JAN 2004, 12 FEB 200.. | 2 0.02 93.86 8 MG/DAY | 1 0.01 93.87 8 MG/KG/D | 1 0.01 93.88 8.6-17.2 MG PRN PO | 1 0.01 93.89 80 DROPS/DAY FOR MORE THAN 2 MONTHS, .. | 1 0.01 93.90 80 MG ONCE PER MONTH EPIDURAL | 1 0.01 93.91 80 MG 1 PER DAY PO | 1 0.01 93.92 80 MG PO QD | 1 0.01 93.93 80 MG PO QHS | 1 0.01 93.94 80 MG Q 8 HR PO | 1 0.01 93.95 80 MG, BID | 1 0.01 93.96 80 MG, QD | 10 0.10 94.06 80 MG, UNK | 2 0.02 94.08 80 MG/12.5 MG | 1 0.01 94.09 80 MG/DAY | 7 0.07 94.16 800 MCG, QD | 1 0.01 94.17 800 MCG, VAGINAL | 1 0.01 94.18 800 MG | 1 0.01 94.19 800 MG ONCE IV | 1 0.01 94.20 800 MG Q24 H IV | 1 0.01 94.21 80MG PER DAY | 4 0.04 94.25 81 MG PO QD | 1 0.01 94.26 8400 MG | 1 0.01 94.27 85 MG/M2 DAY1, Q 2 WEEKS IV | 1 0.01 94.28 850 MG/M2 DAYS 1-7, Q 2 WK PO | 1 0.01 94.29 85MG/BODY=65.4MG/M2 | 1 0.01 94.30 875 MG, QD | 1 0.01 94.31 880 MG | 1 0.01 94.32 880 MG LOADING DOSE INITIATED 16-NOV-.. | 1 0.01 94.33 890 MG | 1 0.01 94.34 8MG PER DAY | 1 0.01 94.35 8MG/500ML USED AS A RINSE | 1 0.01 94.36 9 INFUSIONS | 1 0.01 94.37 9 MG/M^2 (17 MG), INTREAVEOUS | 1 0.01 94.38 90 MG, QMO | 5 0.05 94.43 90 MINUTE INFUSION | 1 0.01 94.44 900 MG, QW2 | 1 0.01 94.45 900 MG/D | 1 0.01 94.46 900 MG/M2 | 1 0.01 94.47 900MG PER DAY | 1 0.01 94.48 960 ML, QD | 1 0.01 94.49 99 MG | 1 0.01 94.50 990 MG | 1 0.01 94.51 ABOUT 4X NORMAL AMOUNT | 1 0.01 94.52 ADDITIONAL INFORMATION RECEIVED ON 6-.. | 1 0.01 94.53 ADMINISTERED 30 MINUTES PRIOR TO CETU.. | 1 0.01 94.54 ADMINISTERED AT THIS DOSE FOR ONE WEE.. | 1 0.01 94.55 ADMINISTERED FOR 5 DAYS EVERY 28 DAYS | 1 0.01 94.56 ALTERNATE DAYS | 1 0.01 94.57 ALTERNATING DOSE OF 20 AND 40MG. | 1 0.01 94.58 AMITRIPTYLINE/ KETAMINE; 2 PERCENT/ 5.. | 1 0.01 94.59 APPROX. 2 PILLS A WEEK | 1 0.01 94.60 APPROXIMATELY | 1 0.01 94.61 AS DIRECTED | 1 0.01 94.62 AS NEEDED | 4 0.04 94.66 AS RECOMMENDED EVERY HOUR OTHER | 1 0.01 94.67 AS REQUIRED | 1 0.01 94.68 AT BEDTIME | 1 0.01 94.69 AT BEDTIME. | 1 0.01 94.70 AT HOURS OF SLEEP AS NEEDED | 1 0.01 94.71 BASELINE | 8 0.08 94.79 BETWEEN SEPT 2004 AND 28 OCT 2005 25 .. | 1 0.01 94.80 BID OR TID | 1 0.01 94.81 COMPLETE REMAINING AMOUNT | 1 0.01 94.82 COMPLETED NINE UNSPECIFIED CYCLES | 1 0.01 94.83 CONCOMITANT THERAPY | 1 0.01 94.84 CYCLE 1, DAY 1 | 1 0.01 94.85 DAILY | 1 0.01 94.86 DAILY DOSE: UNKNOWN | 22 0.22 95.08 DAILY DOSE: UNKNOWN FREQUENCY: 3 TIM.. | 1 0.01 95.09 DAILY DOSE: 1 DOSAGE FORM | 1 0.01 95.10 DAILY DOSE: 2 MILLIGRAM(S) | 1 0.01 95.11 DAILY DOSE: 20 MILLIGRAM(S) | 1 0.01 95.12 DAILY DOSE: 2000 MILLIGRAM(S) | 1 0.01 95.13 DAILY DOSE: 25 MILLIGRAM(S) | 2 0.02 95.15 DAILY DOSE: 30 MILLIGRAM(S) | 2 0.02 95.17 DAILY DOSE: 325 MILLIGRAM(S) | 1 0.01 95.18 DAILY DOSE: 4 MILLIGRAM(S) | 2 0.02 95.20 DAILY DOSE: 450 MILLIGRAM(S) | 1 0.01 95.21 DAILY DOSE: 5 G. | 1 0.01 95.22 DAILY DOSE: 5 GRAM(S) | 1 0.01 95.23 DAILY DOSE: 500 MG/400 IU. | 1 0.01 95.24 DAILY DOSE: 7.5 GRAM(S) | 1 0.01 95.25 DAILY DOSE: 75 MILLIGRAM(S) | 1 0.01 95.26 DAILY DOSE: 750 MILLIGRAM(S) | 1 0.01 95.27 DAILY DOSE: UNK. | 14 0.14 95.41 DAILY PO | 1 0.01 95.42 DAY OF AND DAY AFTER INFLIXIMAB INFUS.. | 1 0.01 95.43 DECREASED TO 200MG - 1 DAILY (PRESENT) | 1 0.01 95.44 DELAYED. MOST RECENT INFUSION 20-JAN.. | 1 0.01 95.45 DELAYED. MOST RECENT INFUSION 19-JAN-.. | 1 0.01 95.46 DISCONTINUED (DATE NOT REPORTED). NO.. | 1 0.01 95.47 DISCONTINUED SEP-2005 VERSUS 17-OCT-2.. | 1 0.01 95.48 DOSAGE FORM = 1 PUFF | 1 0.01 95.49 DOSAGE FORM = 30/500 MG | 1 0.01 95.50 DOSAGE FORM = 300/12.5 MG | 1 0.01 95.51 DOSAGE FORM = 50/250 | 1 0.01 95.52 DOSAGE UNKNOWN | 7 0.07 95.59 DOSE 0.25RG | 1 0.01 95.60 DOSE 12MG, 4MG ORAL | 1 0.01 95.61 DOSE 1SHT OD | 1 0.01 95.62 DOSE = 3 TABS | 1 0.01 95.63 DOSE = 800 RG | 1 0.01 95.64 DOSE EQUATES TO 2150 MG BD | 1 0.01 95.65 DOSE FORM REPORTED AS ORAL FORMULATION | 2 0.02 95.67 DOSE FORM: RECTAL SUPPOSITORY | 1 0.01 95.68 DOSE HELD ON 03-MAR-2006. RESTARTED .. | 1 0.01 95.69 DOSE INCREASED | 1 0.01 95.70 DOSE REDUCED. | 1 0.01 95.71 DOSE REPORTED AS 16 MG/DL | 1 0.01 95.72 DOSE REPORTED AS 37.5/25MG | 1 0.01 95.73 DOSE REPORTED AS 5/500MG | 1 0.01 95.74 DOSE UNIT: UNITS | 2 0.02 95.76 DOSE VALUE: 1/4 MORNING, MIDDAY AND .. | 1 0.01 95.77 DOSE VALUE: 10 MG AM, AND 10 MG PM. | 1 0.01 95.78 DOSE VALUE: ^LONG TERM^ | 1 0.01 95.79 DOSE: 1 G | 1 0.01 95.80 DOSE: 1 MG | 1 0.01 95.81 DOSE: 1 TABLET | 1 0.01 95.82 DOSE: 1 TABLET A DAY | 2 0.02 95.84 DOSE: 100 TO 150 | 1 0.01 95.85 DOSE: 2 CAPSULES A DAY | 1 0.01 95.86 DOSE: 2 G | 1 0.01 95.87 DOSE: 2 PUFFS | 1 0.01 95.88 DOSE: 2 SPRAYS/NOSTRIL | 1 0.01 95.89 DOSE: 2 TABLETS | 2 0.02 95.91 DOSE: 2 TABLETS A DAY | 4 0.04 95.95 DOSE: 20 MG | 1 0.01 95.96 DOSE: 22 UT | 1 0.01 95.97 DOSE: 3 CAPSULES | 1 0.01 95.98 DOSE: 3 CAPSULES A WEEK | 1 0.01 95.99 DOSE: 3 TABLETS | 1 0.01 96.00 DOSE: 4 MG | 1 0.01 96.01 DOSE: 5 MG | 1 0.01 96.02 DOSE: 50 MG | 1 0.01 96.03 DOSE: 500 MG TID | 1 0.01 96.04 DOSE: 6 TABLETS | 1 0.01 96.05 DOSE: 60 MG | 1 0.01 96.06 DOSE: 60 TO 90 | 1 0.01 96.07 DOSE: 75 MG/M2 | 1 0.01 96.08 DOSE: 75 MG/M2 X3 | 1 0.01 96.09 DOSE: ENOX/PLACEBO 100 MG | 1 0.01 96.10 DOSE: ENOX/PLACEBO BOLUS 30 MG | 2 0.02 96.12 DOSE: ENOX/PLACEBO BOLUS NOT GIVEN | 2 0.02 96.14 DOSE: ENOX/PLACEBO SC 57 MG | 1 0.01 96.15 DOSE: ENOX/PLACEBO SC 62 MG | 1 0.01 96.16 DOSE: ENOX/PLACEBO SC 76 MG | 1 0.01 96.17 DOSE: ENOXAPARIN OR PLACEBO 152 MG | 1 0.01 96.18 DOSE: ENOXAPARIN/PLACEBO 30 MG IV | 1 0.01 96.19 DOSE: HEP/PLACEBO 24000 U/DAY; FREQUE.. | 1 0.01 96.20 DOSE: HEP/PLACEBO BOLUS 3240 UNITS | 1 0.01 96.21 DOSE: HEP/PLACEBO BOLUS 4000 UNITS | 1 0.01 96.22 DOSE: HEP/PLACEBO BOLUS NOT GIVEN | 1 0.01 96.23 DOSE: HEP/PLACEBO IV 650 IU | 1 0.01 96.24 DOSE: HEP/PLACEBO IV 650 UNITS/HOUR | 1 0.01 96.25 DOSE: HEPARIN OR PLACEBO 24000 U/HOUR | 1 0.01 96.26 DOSE: HEPARIN OR PLACEBO 4000 U | 1 0.01 96.27 DOSE: HEPARIN/PLACEBO BOLUS NOT GIVEN | 1 0.01 96.28 DOSE: HEPARIN/PLACEBO IV 600 UNITS; F.. | 1 0.01 96.29 DOSE: NOT PROVIDED | 4 0.04 96.33 DOSE: UNK | 55 0.55 96.88 DOSE: UNKNOWN | 19 0.19 97.07 DOSE= 5/500 | 1 0.01 97.08 DOSING = 4 PUFFS | 1 0.01 97.09 DRANK TWO (2) INDIVIDUAL-SERVING BOTT.. | 1 0.01 97.10 DRUG REPORTED AS BENZAGEL-5. | 1 0.01 97.11 DRUG REPORTED AS PENXOYL-10. | 1 0.01 97.12 DRUG REPORTED AS SULFUR BAR. | 1 0.01 97.13 DURATION OF THERAPY: A FEW YEARS | 1 0.01 97.14 DURATION OF THERAPY: ^LONG TERM^ | 2 0.02 97.16 DURATION: MANY YEARS | 1 0.01 97.17 EVERY 4 WEEKS | 1 0.01 97.18 EYE DROP. | 3 0.03 97.21 FOETAL DRUG EXPOSURE VIA FATHER | 1 0.01 97.22 FOR 1 TO 1 1/2 YEARS. IN HOSPITAL | 1 0.01 97.23 FOR FIVE TO SIX WEEKS, BEGINNING THE .. | 1 0.01 97.24 FORM = ORAL FORMULATION NOT OTHERWISE.. | 1 0.01 97.25 FORM: ORAL FORMULATION NOT OTHERWISE .. | 1 0.01 97.26 FORMULATION REPORTED AS ORAL FORMULAT.. | 1 0.01 97.27 FROM 16 FEB 2005 THERAPY INCREASED TO.. | 1 0.01 97.28 GIVEN ON DAYS 1 AND 22 OF A 6 WEEK CY.. | 1 0.01 97.29 HIP AND SPINE | 2 0.02 97.31 IN OFFICE | 8 0.08 97.39 IN THE EVENING | 1 0.01 97.40 INITIAL DOSE 17-MAR-2006 = 500 MG. DO.. | 1 0.01 97.41 INITIAL TX DATE: 14-NOV-05. | 1 0.01 97.42 INITIAL TX DATE: 14-NOV-05. PT REC'D .. | 1 0.01 97.43 INITIAL TX DATE: 14-NOV-05. TOTAL DOS.. | 1 0.01 97.44 INITIATED 10-FEB-2006 = 400 MG/M2 F/B.. | 1 0.01 97.45 INITIATED 10-FEB-2006/TOTAL DOSE ADMI.. | 1 0.01 97.46 INITIATED ON 06-FEB-2006. | 2 0.02 97.48 INITIATED ON 30-JAN-2006. DOSE DELAYE.. | 1 0.01 97.49 INJECTED SLOWLY IN DIVIDED DOSES. | 1 0.01 97.50 INJECTED SLOWLY IN DVIVIDED DOSES. | 1 0.01 97.51 INTERMITTENT USE DOSE | 1 0.01 97.52 INTRADISCAL (INTRASPINAL) | 2 0.02 97.54 INTRAVENOUS | 2 0.02 97.56 INTRAVENOUS NOS | 1 0.01 97.57 IV | 4 0.04 97.61 IV DRIP | 2 0.02 97.63 IV GIVEN PRIOR TO COMMENCING ORAL | 1 0.01 97.64 LOADING DOSE (708 MG). DISCONTINUED A.. | 1 0.01 97.65 LOW DOSAGE | 4 0.04 97.69 MAINTENANCE INFUSIONS FOR APPROXIMATE.. | 1 0.01 97.70 MANNITOL 20% | 1 0.01 97.71 MAXIMUM 5 MG THROUGH PATIENT-CONTROLL.. | 1 0.01 97.72 MONOTHERAPY. | 1 0.01 97.73 MOST RECENT INFUSION 19-JAN-06 (2ND I.. | 1 0.01 97.74 MOTHER: NUMBER OF PRIOR INFLIXIMAB IN.. | 1 0.01 97.75 NO TREATMENT | 1 0.01 97.76 NOT REPORTED | 4 0.04 97.80 NUMBER OF PRIOR INFLIXIMAB INFUSIONS .. | 1 0.01 97.81 ON 15 NOVEMBER 1989 (EST), THE PATIEN.. | 1 0.01 97.82 ON DAY 1-14 EVERY THREE WEEKS | 1 0.01 97.83 ON DAYS 1 TO 15 AND DAYS 22 TO 36 FOR.. | 1 0.01 97.84 ON DAYS ONE AND TWENTY TWO BEFORE IRI.. | 1 0.01 97.85 ON RETIRING | 1 0.01 97.86 ONCE | 2 0.02 97.88 ONCE INTRADERM | 4 0.04 97.92 ONE ONE PER DAY | 1 0.01 97.93 ONE TABLET DAY 1 AT 4:00 AND DAYS 2-5.. | 1 0.01 97.94 ONE TABLET ORALLY EVERY 8-12 HOURS FO.. | 1 0.01 97.95 ONE TABLET THREE TIME DAILY | 1 0.01 97.96 OPHT | 3 0.03 97.99 ORAL | 14 0.14 98.13 PAIN MANAGEMENT | 1 0.01 98.14 PO | 4 0.04 98.18 PRE AND POST TAXOTERE | 1 0.01 98.19 PRN | 1 0.01 98.20 PRN, BID | 1 0.01 98.21 PULSED IV | 1 0.01 98.22 Q WEEK | 1 0.01 98.23 Q20 MIN | 1 0.01 98.24 Q2W OR Q3W | 2 0.02 98.26 Q4WEEKS | 1 0.01 98.27 QD, ORAL | 3 0.03 98.30 ROUTE OF SECOND THERAPY REPORTED AS I.. | 1 0.01 98.31 ROUTE REPORTED AS INJECTABLE. | 1 0.01 98.32 ROUTE WAS REPORTED AS INJECTABLE. REC.. | 1 0.01 98.33 ROUTE- INJECTABLE (NOS). 24 JAN-24 JA.. | 1 0.01 98.34 ROUTE: INJECTION. DURATION REPORTED A.. | 1 0.01 98.35 ROUTE: OROPHARINGEAL FORM: GARGLE | 1 0.01 98.36 SEE IMAGE | 16 0.16 98.52 SEE IMAGE, SUBCUTANEOUS | 1 0.01 98.53 SINCE 20 YEARS | 1 0.01 98.54 SINCE 5 YEARS | 1 0.01 98.55 SIX HOURS APART | 1 0.01 98.56 SMALL AMOUNT TO CLEAN LENSES USED TWICE | 1 0.01 98.57 STILL RECEIVING TREATMENT ON 26 JUN 2.. | 1 0.01 98.58 STOPPED JANUARY 2005, RESTARTED APRIL.. | 2 0.02 98.60 TAKEN AS NEEDED | 1 0.01 98.61 TAKEN AS NEEDED. DOSE FORM REPORTED .. | 1 0.01 98.62 TEMPORARILY STOPPED DUE TO EVENT ON 1.. | 1 0.01 98.63 THERAPY INITIATED 19-OCT-2005. | 2 0.02 98.65 THERAPY START DATE 10-MAR-06. GIVEN O.. | 1 0.01 98.66 THERAPY START DATE 10-MAR-06. GIVEN O.. | 1 0.01 98.67 THERAPY START DATE 27-FEB-06. | 2 0.02 98.69 THERAPY START DATE 27-FEB-2006. | 1 0.01 98.70 TITRATED UP 25MG/WEEK TO 350MG/DAY | 1 0.01 98.71 TOPICAL TO RIGHT HAND AND ARM | 1 0.01 98.72 TOTAL 3 DOSES RECEIVED | 1 0.01 98.73 TOTAL 5 DOSES AT WEEK 0, 2, 4, 8, AND.. | 1 0.01 98.74 TRADE NAME REPORTED AS THYROMONE | 1 0.01 98.75 TWICE DAILY | 2 0.02 98.77 TWO THERAPIES FROM 13 MAR 2002 AT 50 .. | 1 0.01 98.78 UNK | 46 0.46 99.24 UNK, BID | 4 0.04 99.28 UNK, ONCE/SINGLE | 4 0.04 99.32 UNK, PRN | 4 0.04 99.36 UNK, Q48H | 1 0.01 99.37 UNK, QD | 1 0.01 99.38 UNK, QHS | 1 0.01 99.39 UNK, QID | 1 0.01 99.40 UNK, QMO | 1 0.01 99.41 UNK, SINGLE | 1 0.01 99.42 UNK, UNK | 14 0.14 99.56 UNK,UNK | 1 0.01 99.57 UNKNOWN | 27 0.27 99.84 UNKNOWN, ORAL | 2 0.02 99.86 UNKNOWN; ORAL | 1 0.01 99.87 VALS 160/ HCT 12.5 MG/QOD | 1 0.01 99.88 VALS 80 / HCT 12.5 MG/DAY | 2 0.02 99.90 VIA SYRINGE PUMP. | 1 0.01 99.91 WEEK AFTER INFLIXIMAB INFUSION | 1 0.01 99.92 WEEKLY | 1 0.01 99.93 WHEN REQUIRED | 1 0.01 99.94 WITHDRAWN 1 MONTH AFTER INFLIXIMAB IN.. | 2 0.02 99.96 ^ON AND OFF^ | 1 0.01 99.97 ^RE-TITRATION^ | 1 0.01 99.98 ` | 1 0.01 99.99 }Q 2 HR | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015